196 related articles for article (PubMed ID: 34830978)
1. Identification of Gene Co-Expression Networks Associated with Consensus Molecular Subtype-1 of Colorectal Cancer.
Nunez SK; Young CD; Griffen TL; Ohandjo AQ; McKinney LP; Kopetz S; Lillard JW
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830978
[TBL] [Abstract][Full Text] [Related]
2. Consensus molecular subtype classification of colorectal adenomas.
Komor MA; Bosch LJ; Bounova G; Bolijn AS; Delis-van Diemen PM; Rausch C; Hoogstrate Y; Stubbs AP; de Jong M; Jenster G; van Grieken NC; Carvalho B; Wessels LF; Jimenez CR; Fijneman RJ; Meijer GA;
J Pathol; 2018 Nov; 246(3):266-276. PubMed ID: 29968252
[TBL] [Abstract][Full Text] [Related]
3. Stratified analysis reveals chemokine-like factor (CKLF) as a potential prognostic marker in the MSI-immune consensus molecular subtype CMS1 of colorectal cancer.
Dunne PD; O'Reilly PG; Coleman HG; Gray RT; Longley DB; Johnston PG; Salto-Tellez M; Lawler M; McArt DG
Oncotarget; 2016 Jun; 7(24):36632-36644. PubMed ID: 27153559
[TBL] [Abstract][Full Text] [Related]
4. The correlation between immune subtypes and consensus molecular subtypes in colorectal cancer identifies novel tumour microenvironment profiles, with prognostic and therapeutic implications.
Soldevilla B; Carretero-Puche C; Gomez-Lopez G; Al-Shahrour F; Riesco MC; Gil-Calderon B; Alvarez-Vallina L; Espinosa-Olarte P; Gomez-Esteves G; Rubio-Cuesta B; Sarmentero J; La Salvia A; Garcia-Carbonero R
Eur J Cancer; 2019 Dec; 123():118-129. PubMed ID: 31678770
[TBL] [Abstract][Full Text] [Related]
5. Molecular pathological classification of colorectal cancer.
Müller MF; Ibrahim AE; Arends MJ
Virchows Arch; 2016 Aug; 469(2):125-34. PubMed ID: 27325016
[TBL] [Abstract][Full Text] [Related]
6. Refining colorectal cancer classification and clinical stratification through a single-cell atlas.
Khaliq AM; Erdogan C; Kurt Z; Turgut SS; Grunvald MW; Rand T; Khare S; Borgia JA; Hayden DM; Pappas SG; Govekar HR; Kam AE; Reiser J; Turaga K; Radovich M; Zang Y; Qiu Y; Liu Y; Fishel ML; Turk A; Gupta V; Al-Sabti R; Subramanian J; Kuzel TM; Sadanandam A; Waldron L; Hussain A; Saleem M; El-Rayes B; Salahudeen AA; Masood A
Genome Biol; 2022 May; 23(1):113. PubMed ID: 35538548
[TBL] [Abstract][Full Text] [Related]
7. The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer.
Mazzeschi M; Sgarzi M; Romaniello D; Gelfo V; Cavallo C; Ambrosi F; Morselli A; Miano C; Laprovitera N; Girone C; Ferracin M; Santi S; Rihawi K; Ardizzoni A; Fiorentino M; D'Uva G; Győrffy B; Palmer R; Lauriola M
J Exp Clin Cancer Res; 2022 Mar; 41(1):113. PubMed ID: 35351152
[TBL] [Abstract][Full Text] [Related]
8. CMS-dependent prognostic impact of KRAS and BRAFV600E mutations in primary colorectal cancer.
Smeby J; Sveen A; Merok MA; Danielsen SA; Eilertsen IA; Guren MG; Dienstmann R; Nesbakken A; Lothe RA
Ann Oncol; 2018 May; 29(5):1227-1234. PubMed ID: 29518181
[TBL] [Abstract][Full Text] [Related]
9. Exploratory analyses of consensus molecular subtype-dependent associations of
Smeby J; Sveen A; Bergsland CH; Eilertsen IA; Danielsen SA; Eide PW; Hektoen M; Guren MG; Nesbakken A; Bruun J; Lothe RA
ESMO Open; 2019; 4(3):e000523. PubMed ID: 31321083
[TBL] [Abstract][Full Text] [Related]
10. Consensus Molecular Subtypes of Colorectal Cancer and their Clinical Implications.
Thanki K; Nicholls ME; Gajjar A; Senagore AJ; Qiu S; Szabo C; Hellmich MR; Chao C
Int Biol Biomed J; 2017; 3(3):105-111. PubMed ID: 28825047
[TBL] [Abstract][Full Text] [Related]
11. Multi-omics integration identifies a selective vulnerability of colorectal cancer subtypes to YM155.
Zhan T; Faehling V; Rauscher B; Betge J; Ebert MP; Boutros M
Int J Cancer; 2021 Apr; 148(8):1948-1963. PubMed ID: 33186476
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic subtypes predict outcomes in colorectal cancer.
Kasurinen J; Beilmann-Lehtonen I; Kaprio T; Hagström J; Haglund C; Böckelman C
Acta Oncol; 2023 Mar; 62(3):245-252. PubMed ID: 36867078
[TBL] [Abstract][Full Text] [Related]
13. Single-Cell RNA Sequencing Analysis of the Heterogeneity in Gene Regulatory Networks in Colorectal Cancer.
Wang RQ; Zhao W; Yang HK; Dong JM; Lin WJ; He FZ; Cui M; Zhou ZL
Front Cell Dev Biol; 2021; 9():765578. PubMed ID: 34917613
[TBL] [Abstract][Full Text] [Related]
14. [Characterization of patients with sporadic colorectal cancer following the new Consensus Molecular Subtypes (CMS)].
Wielandt AM; Villarroel C; Hurtado C; Simian D; Zamorano D; Martínez M; Castro M; Vial MT; Kronberg U; López-Kostner F
Rev Med Chil; 2017 Apr; 145(4):419-430. PubMed ID: 28748988
[TBL] [Abstract][Full Text] [Related]
15. The prognostic impact of consensus molecular subtypes (CMS) and its predictive effects for bevacizumab benefit in metastatic colorectal cancer: molecular analysis of the AGITG MAX clinical trial.
Mooi JK; Wirapati P; Asher R; Lee CK; Savas P; Price TJ; Townsend A; Hardingham J; Buchanan D; Williams D; Tejpar S; Mariadason JM; Tebbutt NC
Ann Oncol; 2018 Nov; 29(11):2240-2246. PubMed ID: 30247524
[TBL] [Abstract][Full Text] [Related]
16. Cofilin-1, LIMK1 and SSH1 are differentially expressed in locally advanced colorectal cancer and according to consensus molecular subtypes.
Sousa-Squiavinato ACM; Vasconcelos RI; Gehren AS; Fernandes PV; de Oliveira IM; Boroni M; Morgado-Díaz JA
Cancer Cell Int; 2021 Jan; 21(1):69. PubMed ID: 33482809
[TBL] [Abstract][Full Text] [Related]
17. Characterizing heterogeneity along EMT and metabolic axes in colorectal cancer reveals underlying consensus molecular subtype-specific trends.
Sehgal M; Ramu S; Vaz JM; Ganapathy YR; Muralidharan S; Venkatraghavan S; Jolly MK
Transl Oncol; 2024 Feb; 40():101845. PubMed ID: 38029508
[TBL] [Abstract][Full Text] [Related]
18. Investigation of colorectal cancer in accordance with consensus molecular subtype classification.
Sawayama H; Miyamoto Y; Ogawa K; Yoshida N; Baba H
Ann Gastroenterol Surg; 2020 Sep; 4(5):528-539. PubMed ID: 33005848
[TBL] [Abstract][Full Text] [Related]
19. Consensus molecular subtypes of colorectal cancer in clinical practice: A translational approach.
Valenzuela G; Canepa J; Simonetti C; Solo de Zaldívar L; Marcelain K; González-Montero J
World J Clin Oncol; 2021 Nov; 12(11):1000-1008. PubMed ID: 34909395
[TBL] [Abstract][Full Text] [Related]
20. Host-microbiota interactions contributing to the heterogeneous tumor microenvironment in colorectal cancer.
Li X; Wu D; Li Q; Gu J; Gao W; Zhu X; Yin W; Zhu R; Zhu L; Jiao N
Physiol Genomics; 2024 Feb; 56(2):221-234. PubMed ID: 38073489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]